SINGAPORE – May 25, 2025 – In a landmark announcement that bridges Asia and Europe, Leo International Group has acquired a controlling stake in SPOABG AG, a publicly listed company on the Frankfurt Stock Exchange (FSE). The company has now been officially renamed Leo International Precision Health AG (LIPH AG), with updated ticker symbols “LEOW.F” and “LEOW.DU”.
This momentous move marks the first time in a century that a Taiwanese-founded enterprise has achieved mainboard listing status on Germany’s prestigious Frankfurt Stock Exchange. It represents a major milestone in Leo International’s global expansion strategy and underlines its commitment to advancing AI-powered precision health across continents.
A Vision Rooted in Humanity, Realized Globally
Founded in 1926, Leo International Group is a fourth-generation family-owned enterprise headquartered in Taiwan, with a mission rooted in “Caring for People,…
Read more…
